A Phase3, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu64PSMAI & TPET/CT in Men with Biochemical Recurrence of Prostate Cancer (SOLAR 002)
SOLAR 002 is a prospective phase 3 study that focuses on determining the accuracy of copper Cu 64 PSMA I&T PET/CT in the diagnosis of biochemical recurrence of prostate cancer.
Principal Investigator: Dr. Medhat Osman
Study Coordinator: Brittany Minor
This study is now enrolling patients.
To learn more about the SOLAR RECUR 002 trial and how you can join contact our research office at (314) 289-7690.
This studies are funded by the Foundation through the sponsor CURIUM
Study Coordinator: Brittany Minor
This study is now enrolling patients.
To learn more about the SOLAR RECUR 002 trial and how you can join contact our research office at (314) 289-7690.
This studies are funded by the Foundation through the sponsor CURIUM